Pfizer (PFE) PT Lowered to $44 at Morgan Stanley
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $26.80 +1.86%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn lowered the price target on Pfizer (NYSE: PFE) to $44.00 (from $45.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Bank Polska Kasa Opieki S.A. (PEO:PW) (BKPKF) PT Raised to PLN261 at Barclays
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
